Commonwealth Equity Services
AGTC

Commonwealth Equity Services’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Commonwealth Equity Services’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,064
Closed -$9K – 3796
2022
Q2 		$9K Sell
12,064
-600
-5% -$535 ﹤0.01% 3630
2022
Q1 		$13K Buy
12,664
+2,050
+19% +$3.73K ﹤0.01% 3680
2021
Q4 		$20K Buy
+10,614
New +$25.4K ﹤0.01% 3604

Other funds holding AGTC

PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Commonwealth Equity Services's AGTC Position: Q3 2022 in Review

Commonwealth Equity Services sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2022, closing a stake of 12,064 shares — an estimated $9K sold.

Commonwealth Equity Services first reported a position in AGTC in Q4 2021 and held it in 3 quarters. The position peaked at $20K in Q4 2021. 45 funds tracked by Wall St. Rank hold AGTC as of Q3 2022.

  • Commonwealth Equity Services reported no remaining Applied Genetic Technologies Corporation position as of Q3 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 12,064 Applied Genetic Technologies Corporation shares in Q3 2022, an estimated $9K.
  • Commonwealth Equity Services first reported a position in Applied Genetic Technologies Corporation in Q4 2021 and held it in 3 quarters.
  • Commonwealth Equity Services's Applied Genetic Technologies Corporation position peaked at $20K in Q4 2021.
  • 45 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2022.

Based on Commonwealth Equity Services's 13F filing for Q3 2022, filed 14 Nov 2022.